Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02082145
Other study ID # 13/LO/1844
Secondary ID 13HH1825
Status Completed
Phase N/A
First received
Last updated
Start date July 2014
Est. completion date December 2015

Study information

Verified date October 2020
Source Imperial College London
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess the effect of the device on the progression of diabetic peripheral neuropathy


Description:

Diabetes is a metabolic disease that affects the body's ability to control blood sugar levels. This affects the tissues of the body, particularly the walls of blood vessels. People with diabetes are more likely to suffer from ischaemic heart disease, stroke, kidney problems, blindness, foot ulcers, and peripheral nerve problems. Diabetes affects approximately 347 million people worldwide, and by 2030 the WHO projects that complications of diabetes will be the 7th leading cause of death. Peripheral neuropathy is a dysfunction of the nerves most commonly affecting the arms and legs. Diabetes is the leading cause of neuropathy in the Western world, and diabetic neuropathy is estimated to affect between 20-50% of diabetic people. The American Diabetes Association define it as the 'presence of symptoms and signs of peripheral nerve dysfunction in patients with diabetes after exclusion of other causes'. As regards complications of diabetes, peripheral neuropathy has the greatest detrimental effect on quality of life. Diabetic neuropathy is implicated in 50-75% of non-traumatic amputations. The device to be tested mimics the effect of walking by stimulating the motor nerves of the leg, making the foot twitch- it increases blood flow to the limb and exercises the leg muscles. We have seen previous clinical cases of improvement in peripheral neuropathy with use of the device, and wish to formalise the benefits to patients. It is hypothesised to work either by increasing blood flow to the limb and therefore the nerves themselves, or for electrical current to be having a direct effect on the peripheral nervous system itself. The device is easily fitted, can be self-administered by patients, and is suitable for out-patient therapy. We wish to evaluate both the short- and longer-term effects of a neuromuscular stimulator on diabetic peripheral neuropathy as a therapeutic intervention.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria - 18+ years old - Diabetes as defined by WHO diagnostic criteria on best medical therapy - Diabetic peripheral polyneuropathy present, confirmed by nerve conduction testing Exclusion criteria - Pregnancy - Pacemaker - Metal implants in the legs (below knee)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
NMES
Application of NMES device bilaterally, once a day, 5 times a week, for 10 weeks

Locations

Country Name City State
United Kingdom Academic Vascular Surgery, Charing Cross Hospital London

Sponsors (1)

Lead Sponsor Collaborator
Imperial College London

Country where clinical trial is conducted

United Kingdom, 

References & Publications (2)

Balducci S, Iacobellis G, Parisi L, Di Biase N, Calandriello E, Leonetti F, Fallucca F. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabetes Complications. 2006 Jul-Aug;20(4):216-23. — View Citation

Kluding PM, Pasnoor M, Singh R, Jernigan S, Farmer K, Rucker J, Sharma NK, Wright DE. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complications. 2012 Sep-Oct;26(5):424-9. doi: 10.1016/j.jdiacomp.2012.05.007. Epub 2012 Jun 18. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Nerve Conduction Speed (Common Peroneal Nerve) Baseline, 10 weeks
Secondary PAID - Quality of Life Questionnaires PAID (Problem Areas in Diabetes) is a self-administered 20-item scale. Each item is scored from 0 (not a problem) to 4 (serious problem). The sum of all item scores multiplied by 1.25 gives the total PAID score, which ranges from 0 to 100, higher scores reflecting greater emotional distress. Baseline, 10 weeks
See also
  Status Clinical Trial Phase
Completed NCT03216213 - Evaluating Attitudes Towards Organ Donation in Singapore N/A
Completed NCT01571258 - Text4Diet: A Text Messaging Program for Weight Loss N/A
Recruiting NCT03912597 - VR-assisted Curriculum on Depression for Stigma Reduction N/A
Completed NCT00164307 - Assisting Children With Prenatal Alcohol Exposure in Developing Peer Friendships Phase 1/Phase 2
Completed NCT00164528 - Intervening With Children/Adolescents With FAS/ARND Phase 1/Phase 2
Completed NCT03238300 - Neuroscience-Informed Treatment Development for Adolescent Alcohol Use Phase 2
Completed NCT03602248 - Speed Endurance Training, Muscle Damage and Performance in Soccer Players N/A
Completed NCT06197464 - FLOAT Through Anxiety: Virtual Reality Application's Efficacy as a Tool to Distract From Negative Emotions and Thoughts N/A
Completed NCT06242548 - How Type I Diabetes Responds to Different Diets (Normoglucidic or Ketogenic) During Physical Activity at Altitude N/A
Recruiting NCT05517811 - Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Recruiting NCT05321342 - Coaching Teachers in Bullying Detection and Intervention N/A
Recruiting NCT05337410 - Youth Empowerment Solutions: Engaging Youth for Anti Racism and Cultural Equity N/A
Recruiting NCT06264011 - Discrimination and Religious Experiences of Adult Muslimahs in Salaat N/A
Not yet recruiting NCT06116292 - Impact of the Implementation of a Telemedicine Program on Patients Diagnosed With Asthma N/A
Completed NCT04557566 - ED Recovery Course Online RCT N/A
Completed NCT00856726 - Racial Differences in Phosphorus Metabolism N/A
Completed NCT03476200 - Efficacy of Cognitive Behavioral Therapy and Hair Cortisol Concentration N/A
Withdrawn NCT05559944 - Brief Writing Programs for Sexual Minority Young Adults in Alabama N/A
Completed NCT02128737 - Neurobehavioral Effects of Partial Sleep Deprivation N/A
Completed NCT01324661 - The Protective Effect of Friendship on Peer Rejection in Overweight and Normal Weight Youth N/A